About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
exaly
›
Institutions
›
University of Rochester
›
School of Medicine and Dentistry
›
Top Articles
School of Medicine and Dentistry
University of Rochester
357
Articles
12.6K
Citations
2.9
avg. Impact Factor
55
h-index
Most Cited Articles of School of Medicine and Dentistry in 2017
Title
Journal
Year
Citations
Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation
Biology of Blood and Marrow Transplantation
2017
89
Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL
Blood Advances
2017
43
Poor compliance with adjuvant chemotherapy use associated with poorer survival in patients with rectal cancer: An NCDB analysis
Cancer
2017
37
The Older Adult With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: Knowledge Gaps and Future Direction in Assessment and Treatment
International Journal of Radiation Oncology Biology Physics
2017
30
Chemotherapy-induced peripheral neuropathy clinical trials: Review and recommendations
Neurology
2017
28
Is There Evidence for the Presence and Relevance of the PD-1/PD-L1 Pathway in Oral Squamous Cell Carcinoma? Hints From an Immunohistochemical Study
Journal of Oral and Maxillofacial Surgery
2017
25
Understanding the New WHO Classification of Lymphoid Malignancies: Why It's Important and How It Will Affect Practice
American Society of Clinical Oncology Educational Book / ASCO American Society of Clinical Oncology Meeting
2017
14
INTEGRATED ANALYSIS: OUTCOMES OF IBRUTINIB-TREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LEUKEMIA (CLL/SLL) WITH HIGH-RISK PROGNOSTIC FACTORS
Hematological Oncology
2017
12
RISK-ADAPTED THERAPY IN ADULTS WITH BURKITT LYMPHOMA: UPDATED RESULTS OF a MULTICENTER PROSPECTIVE PHASE II STUDY OF DA-EPOCH-R
Hematological Oncology
2017
10
Phase I clinical trial of the base excision repair inhibitor methoxyamine in combination with fludarabine for patients with advanced hematologic malignancies
Oncotarget
2017
10
Patterns of Diagnosis and Misdiagnosis in Pediatric Cancer and Relationship to Survival
Journal of Pediatric Hematology/Oncology
2017
8
ABO identical and washed blood transfusions as candidate strategies to reduce early mortality in acute promyelocytic leukemia
Leukemia Research
2017
7
Novel Therapies in Platinum-refractory Metastatic Germ Cell Tumor: A Case Report with a Focus on a PD-1 Inhibitor
Rare Tumors
2017
7
Thrombosis in a bleeding disorder: case of thromboembolism in factor VII deficiency
Clinical Case Reports (discontinued)
2017
6
A Bacterial Cause of Cancer: An Historical Essay
Oncologist
2017
5
PRODUCT CHARACTERISTICS ASSOCIATED WITH IN VIVO EXPANSION OF ANTI-CD19 CAR T CELLS IN PATIENTS TREATED WITH AXICABTAGENE CILOLEUCEL (AXI-CEL)
Hematological Oncology
2017
1
AUTOLOGOUS TRANSPLANTATION IMPROVES SURVIVAL IN PATIENTS WITH FOLLICULAR LYMPHOMA EXPERIENCING EARLY THERAPY FAILURE AFTER FRONTLINE CHEMOIMMUNOTHERAPY: AN NLCS AND CIBMTR ANALYSIS
Hematological Oncology
2017
1
IBRUTINIB INCREASES THE SYSTEMIC EXPOSURE OF RITUXIMAB: PHARMACOKINETIC RESULTS FROM THE HELIOS TRIAL
Hematological Oncology
2017
1
A PILOT STUDY OF BRENTUXIMAB VEDOTIN AND AVD CHEMOTHERAPY FOLLOWED BY 20 GY INVOLVED-SITE RADIOTHERAPY IN EARLY STAGE, UNFAVORABLE RISK HODGKIN LYMPHOMA
Hematological Oncology
2017
SIMULTANEOUS DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) AND FOLLICULAR LYMPHOMA (FL) AT THE DIAGNOSIS HAS SIMILAR OUTCOME AS DLBCL
Hematological Oncology
2017
Schools/Departments
The list of schools/departments is not comprehensive since it is common to drop the department in the affiliation.
site/software ©
exaly
; All materials licenced under
CC by-SA
.